Aibo Nord (Beijing) Medical Technology Co., Ltd. Discloses 2025 Related-Party Fund Transactions, Primarily Comprising Subsidiary Loans

China Interview Network DataEyebright Medical Technology (Beijing) Co., Ltd. recently disclosed the special audit report on the non-operating fund occupation and other related fund transactions for the 2025 fiscal year. The report shows that, as of the end of 2025, there was no non-operating fund occupation by the controlling shareholder, actual controller, or their affiliated enterprises. Regarding other related fund transactions, these mainly involved intercompany loans between the company and several of its subsidiaries. The total balance of related fund transactions at the end of the period was approximately 644 million yuan, all classified as non-operating transactions. Among these, loans to subsidiaries such as Eyebright Medical Device (Suzhou) Co., Ltd., Jiangsu Tianyan Medicine Technology Co., LTD, and Beijing Eyebright Investment Management Co., Ltd. constituted the majority of the transaction balances, with interest charged on some of the loans. These transactions reflect the company's internal capital allocation and support within the group.